Medicare Enrolled
Dr. Jamuna Rajasingham, M.D.
Neurology · Englewood, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rajasingham from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rajasingham?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rajasingham
Dr. Jamuna Rajasingham is a neurology specialist in Englewood, NJ, with 17 years of NPI registration. Based on federal Medicare data, Dr. Rajasingham performed 1,200 Medicare services across 837 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rajasingham received a total of $22,471 from 80 pharmaceutical and/or device companies across 977 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rajasingham is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 30% volume in NJ
$22,471 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,200
Medicare services
Top 30% in NJ for neurology
837
Unique beneficiaries
$103
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~71 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
466 | $68 | $160 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
194 | $107 | $300 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
165 | $102 | $230 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
114 | $180 | $485 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
103 | $147 | $325 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
42 | $85 | $315 |
| New patient office visit, complex (60-74 min) | 36 | $187 | $460 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
29 | $78 | $165 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
20 | $144 | $445 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
17 | $85 | $520 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
14 | $160 | $685 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$22,471
Total received (2018-2024)
Avg $3,210/year across 7 years
Top 15% in NJ for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
80
Companies
977
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,405 (99.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$66 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,021
2023
$5,215
2022
$3,898
2021
$3,134
2020
$1,592
2019
$2,484
2018
$1,127
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Teva Pharmaceuticals USA, Inc.
$1,027
ACADIA Pharmaceuticals Inc
$339
ABBVIE INC.
$325
Eisai Inc.
$272
SK Life Science, Inc.
$262
Biogen, Inc.
$256
Neurocrine Biosciences, Inc.
$236
EMD Serono, Inc.
$235
Amgen Inc.
$186
PFIZER INC.
$177
Otsuka America Pharmaceutical, Inc.
$176
MDD US Operations, LLC
$135
Novartis Pharmaceuticals Corporation
$134
Avadel CNS Pharmaceuticals, LLC
$125
GENZYME CORPORATION
$120
HARMONY BIOSCIENCES LLC
$118
E.R. Squibb & Sons, L.L.C.
$117
Celgene Corporation
$110
ARGENX US, INC.
$91
Kyowa Kirin, Inc.
$88
Lundbeck LLC
$67
Neurelis, Inc.
$51
UCB, Inc.
$51
Aucta Pharmaceuticals, Inc.
$49
Azurity Pharmaceuticals, Inc.
$33
JAZZ PHARMACEUTICALS INC.
$30
Harmony Biosciences Llc
$29
CATALYST PHARMACEUTICALS, INC.
$24
GE HEALTHCARE
$20
TG Therapeutics, Inc.
$19
Alexion Pharmaceuticals, Inc.
$18
CSL Behring
$17
Acorda Therapeutics, Inc
$17
Ipsen Biopharmaceuticals, Inc
$17
Life Molecular Imaging Ltd
$17
AstraZeneca Pharmaceuticals LP
$16
Lilly USA, LLC
$14
Top 3 companies account for 33.7% of 2024 payments
All-time payments by company (2018-2024) ›
Teva Pharmaceuticals USA, Inc.
$5,038
ABBVIE INC.
$1,863
EMD Serono, Inc.
$1,752
Neurocrine Biosciences, Inc.
$1,383
ACADIA Pharmaceuticals Inc
$1,102
Biogen, Inc.
$966
Novartis Pharmaceuticals Corporation
$717
SK Life Science, Inc.
$671
Celgene Corporation
$493
CSL Behring
$480
Abbott Laboratories
$445
Allergan, Inc.
$418
Eisai Inc.
$381
Amgen Inc.
$368
GENZYME CORPORATION
$355
Otsuka America Pharmaceutical, Inc.
$346
MDD US Operations, LLC
$309
PFIZER INC.
$302
E.R. Squibb & Sons, L.L.C.
$292
Lilly USA, LLC
$285
Medtronic Vascular, Inc.
$285
Harmony Biosciences LLC
$259
AbbVie Inc.
$246
Biohaven Pharmaceuticals, Inc.
$228
Alexion Pharmaceuticals, Inc.
$219
Allergan Inc.
$211
AstraZeneca Pharmaceuticals LP
$198
ARGENX US, INC.
$175
Lundbeck LLC
$157
Kyowa Kirin, Inc.
$152
HARMONY BIOSCIENCES LLC
$147
Adamas Pharmaceuticals, Inc.
$145
UCB, Inc.
$134
Avadel CNS Pharmaceuticals, LLC
$125
Acorda Therapeutics, Inc
$124
Janssen Pharmaceuticals, Inc
$119
TG THERAPEUTICS, INC.
$103
IMPEL PHARMACEUTICALS INC.
$84
Vertos Medical, Inc.
$75
JAZZ PHARMACEUTICALS INC.
$73
AbbVie, Inc.
$72
Neurelis, Inc.
$68
Supernus Pharmaceuticals, Inc.
$60
Alnylam Pharmaceuticals Inc.
$58
Biohaven Pharmaceutical Holding Company Ltd.
$56
Azurity Pharmaceuticals, Inc.
$53
Aucta Pharmaceuticals, Inc.
$49
W. L. Gore & Associates, Inc.
$46
Greenwich Biosciences, Inc.
$45
Impax Laboratories, Inc.
$44
Vertical Pharmaceuticals, LLC
$44
Mallinckrodt LLC
$44
CATALYST PHARMACEUTICALS, INC.
$43
Octapharma USA, Inc.
$40
LivaNova USA, Inc.
$38
Axsome Therapeutics, Inc.
$30
Avanir Pharmaceuticals, Inc.
$30
Harmony Biosciences Llc
$29
ASSERTIO THERAPEUTICS, Inc.
$28
Amneal Pharmaceuticals LLC
$28
AQUESTIVE THERAPEUTICS, INC.
$27
Grifols USA, LLC
$27
GE HEALTHCARE
$20
TG Therapeutics, Inc.
$19
Strongbridge US INC.
$18
Mallinckrodt Enterprises LLC
$18
Ipsen Biopharmaceuticals, Inc
$17
Life Molecular Imaging Ltd
$17
Corium, LLC
$17
Merck Sharp & Dohme LLC
$16
ARBOR PHARMACEUTICALS, INC.
$16
EISAI INC.
$16
Genentech USA, Inc.
$15
Almatica Pharma LLC
$15
Arbor Pharmaceuticals, Inc.
$15
UPSHER-SMITH LABORATORIES LLC
$15
Avion Pharmaceuticals
$15
BANNER LIFE SCIENCES, LLC
$14
Assertio Therapeutics, Inc.
$14
Jazz Pharmaceuticals Inc.
$13
Top 3 companies account for 38.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · ANDEXXA · APOKYN · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Amplia MRI · Apokyn · Austedo XR · Azstarys · BAFIERTAM · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · Briviact · CAMBIA · Cambia · DAYBUE · DUOPA · Dhivy · Duopa · Dysport · EMGALITY · EPIDIOLEX · Epidiolex · FARXIGA · FIRDAPSE · Fycompa · GILENYA · GOCOVRI · GORE CARDIOFORM Septal Occluder · Gamunex-C · Gocovri · HORIZANT · Hizentra · Horizant · INBRIJA · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KEVEYIS · LUMRYZ · LYRICA · Leqembi · MAVENCLAD · MAYZENT · Mavenclad · Motpoly XR · NAPRELAN · NEURACEQ · NORTHERA · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONPATTRO · OSMOLEX ER · Ongentys · PANZYGA · Ponvory · QALSODY · QULIPTA · REXULTI · RYTARY · Rebif · Reveal LINQ · SOLIRIS · SUNOSI · SYMPAZAN · Soliris · Sunosi · TECFIDERA · TOSYMRA · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS Therapy · VYEPTI · VYVGART · VYVGART HYTRULO · WAKIX · Wakix · XADAGO · XCOPRI · XYREM · XYWAV · ZEPOSIA · Zilbrysq · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
1,271
Per 100K population
133.1
County median income
$123,715
Nearest hospital
ENGLEWOOD HOSPITAL AND MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rajasingham is a mixed practice specialist, with above-average Medicare volume (top 30% in NJ), with low-engagement industry engagement in the top 15% of NJ peers, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rajasingham experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Rajasingham performed 466 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rajasingham receive payments from pharmaceutical companies?
Yes. Dr. Rajasingham received a total of $22,471 from 80 companies across 977 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rajasingham's costs compare to other neurologists in Englewood?
Dr. Rajasingham's average Medicare payment per service is $103. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rajasingham) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Englewood
Browse neurologists in Englewood ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NJ
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NJ
Which NJ neurologists receive the most from drug and device companies.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
EMD Serono, Inc. Payments to Doctors
See all physicians who received payments from EMD Serono, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology